Management of acral lentiginous melanoma: current updates and future directions.
Journal Information
Full Title: Front Oncol
Abbreviation: Front Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest Dr. JZ has received Honoraria from the Advisory Board of Delcath Systems. He has consulting agreements with Philogen, Merrit Medical, Castle Biosciences, and Merck. His institutional department receives research funding from Philogen, SWOG, Delcath Systems, and Provectus. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer SP declared a shared affiliation with the authors to the handling editor at the time of review."
"The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025